Salubrious,
I like NTI for 3 reasons:
1)Their proprietary cannabinoid strains, which appear to have some unique anti inflammatory characteristics.
Mente— to me it’s sh-t —only a cost with limited or no upside.
2) The fund that has bought into the company.
3) It looks to have pulled me out of another bad investment— you know what that is.
I haven’t sold any NTI, so only long and going for the ride.
Ann: Neurotech initiates Phase I/II Open Label Study into Autism, page-26
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $70.19M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 11343 | 1 |
View Market Depth
| Last trade - 08.47am 26/07/2024 (20 minute delay) ? |
| NTI (ASX) Chart |
Day chart unavailable